SI-BONE, Inc. (SIBN)
SIBN Stock Price Chart
Explore SI-BONE, Inc. interactive price chart. Choose custom timeframes to analyze SIBN price movements and trends.
SIBN Company Profile
Discover essential business fundamentals and corporate details for SI-BONE, Inc. (SIBN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
17 Oct 2018
Employees
349.00
Website
https://si-bone.comCEO
Laura A. Francis
Description
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
SIBN Financial Timeline
Browse a chronological timeline of SI-BONE, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 9 Nov 2026
EPS estimate is -$0.13, while revenue estimate is $55.72m.
Upcoming earnings on 3 Aug 2026
EPS estimate is -$0.15, while revenue estimate is $55.27m.
Earnings released on 11 May 2026
EPS came in at -$0.10 surpassing the estimated -$0.17 by +41.18%, while revenue for the quarter reached $52.59m , beating expectations by +2.80%.
Earnings released on 23 Feb 2026
EPS came in at -$0.04 surpassing the estimated -$0.13 by +69.23%, while revenue for the quarter reached $56.35m , beating expectations by +1.72%.
Earnings released on 10 Nov 2025
EPS came in at -$0.11 surpassing the estimated -$0.16 by +31.25%, while revenue for the quarter reached $48.66m , missing expectations by -13.52%.
Earnings released on 4 Aug 2025
EPS came in at -$0.14 surpassing the estimated -$0.19 by +26.32%, while revenue for the quarter reached $48.63m , beating expectations by +4.19%.
Earnings released on 5 May 2025
EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%, while revenue for the quarter reached $47.29m , beating expectations by +1.24%.
Earnings released on 24 Feb 2025
EPS came in at -$0.11 surpassing the estimated -$0.15 by +24.38%, while revenue for the quarter reached $49.00m , beating expectations by +1.80%.
Earnings released on 12 Nov 2024
EPS came in at -$0.16 surpassing the estimated -$0.22 by +27.27%, while revenue for the quarter reached $40.34m , missing expectations by -13.97%.
Earnings released on 5 Aug 2024
EPS came in at -$0.22 surpassing the estimated -$0.26 by +15.38%, while revenue for the quarter reached $39.97m , beating expectations by +4.30%.
Earnings released on 6 May 2024
EPS came in at -$0.27 surpassing the estimated -$0.29 by +6.90%, while revenue for the quarter reached $37.87m , beating expectations by +3.77%.
Earnings released on 26 Feb 2024
EPS came in at -$0.27 surpassing the estimated -$0.29 by +6.90%, while revenue for the quarter reached $38.86m , beating expectations by +3.32%.
Earnings released on 6 Nov 2023
EPS came in at -$0.25 surpassing the estimated -$0.33 by +24.24%, while revenue for the quarter reached $34.01m , missing expectations by -6.91%.
Earnings released on 7 Aug 2023
EPS came in at -$0.30 surpassing the estimated -$0.41 by +26.83%, while revenue for the quarter reached $33.31m , beating expectations by +6.71%.
Earnings released on 1 May 2023
EPS came in at -$0.32 surpassing the estimated -$0.41 by +21.95%, while revenue for the quarter reached $32.71m , beating expectations by +5.37%.
Earnings released on 27 Feb 2023
EPS came in at -$0.32 surpassing the estimated -$0.42 by +23.81%, while revenue for the quarter reached $31.95m , beating expectations by +1.43%.
Earnings released on 7 Nov 2022
EPS came in at -$0.41 surpassing the estimated -$0.45 by +8.89%, while revenue for the quarter reached $26.43m , missing expectations by 0.00%.
Earnings released on 8 Aug 2022
EPS came in at -$0.54 falling short of the estimated -$0.49 by -10.20%, while revenue for the quarter reached $25.59m , beating expectations by +1.63%.
Earnings released on 9 May 2022
EPS came in at -$0.52 falling short of the estimated -$0.43 by -20.93%, while revenue for the quarter reached $22.44m , beating expectations by +2.61%.
Earnings released on 28 Feb 2022
EPS came in at -$0.43 falling short of the estimated -$0.37 by -16.22%, while revenue for the quarter reached $25.23m , beating expectations by +2.12%.
Earnings released on 8 Nov 2021
EPS came in at -$0.48 falling short of the estimated -$0.41 by -17.07%, while revenue for the quarter reached $22.29m , missing expectations by -9.22%.
Earnings released on 2 Aug 2021
EPS came in at -$0.42 falling short of the estimated -$0.39 by -7.69%, while revenue for the quarter reached $22.19m , meeting expectations.
SIBN Stock Performance
Access detailed SIBN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
